Encyclopedia

  • Case ReportDigoxin-specific Fab and therapeutic plasma exchange for Digitalis (cas 1339-93-1) intoxication and renal failure
  • Add time:08/30/2019         Source:sciencedirect.com

    Treatment of chronic Digitalis (cas 1339-93-1) intoxication includes suspension of drug intake, which may be sufficient in case of mild manifestations, and supportive measures. Severe bradycardia requires the administration of atropine or isoproterenol; placement of a temporary pacemaker may be required in case of absent response to pharmacological therapy. Severe and life-threatening manifestations should be treated with digoxin-specific fragment antigen binding antibodies (Fab). Therapeutic plasma exchange has been suggested, in addition to Fab therapy, to maximize the clearance of Fab-digoxin complexes in patients with renal failure. To date, few case reports have described the use of such a therapeutic approach; currently, extracorporeal methods are not recommended as part of the treatment of digitalis intoxication, and stronger evidence is required to establish their benefit.

    We also recommend Trading Suppliers and Manufacturers of Digitalis (cas 1339-93-1). Pls Click Website Link as below: cas 1339-93-1 suppliers


    Prev:A green and facile production of catalysts from waste red mud for the one-pot synthesis of glycerol carbonate from glycerol
    Next: Effect of Digitalis (cas 1339-93-1) level on readmission and mortality rate among heart failure reduced ejection fraction patients)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View